Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Response in Japanese link for cardiac tests:

This article was originally published in Clinica

Executive Summary

International Reagents is to buy an exclusive option to evaluate Response Biomedical's RAMP point-of-care cardiac diagnostic system in Japan. The two companies envisage that Vancouver, British Columbia-based Response will develop and manufacture tests for the three main cardiac markers to diagnose heart attack. International Reagents, a subsidiary of Yoshitomi Pharmaceutical Industries based in Kobe, Japan, will fund the trials, registration, sales and marketing in Japan and will receive a share in the profits. Financial terms were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079284

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel